| Primary |
| Asthma |
9.9% |
| Rhinitis Allergic |
9.5% |
| Urticaria |
9.1% |
| Seasonal Allergy |
8.7% |
| Dermatitis Atopic |
8.3% |
| Hypersensitivity |
8.3% |
| Hypertension |
6.3% |
| Eczema |
5.9% |
| Conjunctivitis Allergic |
5.1% |
| Pruritus |
5.1% |
| Otitis Media Acute |
4.7% |
| Rhinitis |
2.8% |
| Rhinorrhoea |
2.8% |
| Loss Of Consciousness |
2.4% |
| Bronchitis |
2.0% |
| Dermatitis |
2.0% |
| Nasopharyngitis |
2.0% |
| Osteoarthritis |
2.0% |
| Cardiac Disorder |
1.6% |
| Constipation |
1.6% |
|
| Convulsion |
20.3% |
| Somnolence |
13.5% |
| Pyrexia |
12.8% |
| Febrile Convulsion |
7.4% |
| Loss Of Consciousness |
5.4% |
| Haematuria |
4.7% |
| Syncope |
4.1% |
| Epilepsy |
3.4% |
| Speech Disorder |
3.4% |
| Vomiting |
3.4% |
| Urine Colour Abnormal |
2.7% |
| Urticaria |
2.7% |
| Blood Alkaline Phosphatase Increased |
2.0% |
| Gastric Lavage |
2.0% |
| Hypersensitivity |
2.0% |
| Oedema Peripheral |
2.0% |
| Pneumonia |
2.0% |
| Pollakiuria |
2.0% |
| Skin Irritation |
2.0% |
| Stevens-johnson Syndrome |
2.0% |
|
| Secondary |
| Otitis Media Acute |
22.2% |
| Drug Use For Unknown Indication |
13.1% |
| Urticaria |
11.8% |
| Dermatitis Atopic |
6.8% |
| Pneumonia |
6.8% |
| Nasopharyngitis |
5.4% |
| Product Used For Unknown Indication |
5.4% |
| Osteoporosis |
3.2% |
| Pruritus |
3.2% |
| Convulsion |
2.7% |
| Infection Prophylaxis |
2.7% |
| Otitis Media |
2.3% |
| Rhinitis Allergic |
2.3% |
| Asthma Prophylaxis |
1.8% |
| Eczema |
1.8% |
| Herpes Zoster |
1.8% |
| Hypersensitivity |
1.8% |
| Sedation |
1.8% |
| Stem Cell Transplant |
1.8% |
| Constipation |
1.4% |
|
| Pyrexia |
12.3% |
| Convulsion |
10.5% |
| Somnolence |
10.5% |
| Erythema Multiforme |
7.0% |
| Dermatitis Exfoliative |
5.3% |
| Hepatic Steatosis |
5.3% |
| Petit Mal Epilepsy |
5.3% |
| Skin Irritation |
5.3% |
| Speech Disorder |
5.3% |
| Incorrect Dose Administered |
3.5% |
| Loss Of Consciousness |
3.5% |
| Mydriasis |
3.5% |
| Post Procedural Complication |
3.5% |
| Rhabdomyolysis |
3.5% |
| Staphylococcal Infection |
3.5% |
| Thrombocytopenic Purpura |
3.5% |
| Vitreous Floaters |
3.5% |
| Allergic Granulomatous Angiitis |
1.8% |
| Amnesia |
1.8% |
| Coagulation Factor Viii Level Decreased |
1.8% |
|
| Concomitant |
| Asthma |
17.3% |
| Product Used For Unknown Indication |
11.2% |
| Prophylaxis |
10.0% |
| Hepatitis C |
9.0% |
| Rhinitis Allergic |
6.6% |
| Hypertension |
5.5% |
| Drug Use For Unknown Indication |
5.0% |
| Constipation |
3.5% |
| Dermatitis Atopic |
3.4% |
| Heart Transplant |
3.4% |
| Hyperlipidaemia |
3.2% |
| Otitis Media |
3.0% |
| Bronchitis |
2.9% |
| Pain |
2.8% |
| Schizophrenia |
2.4% |
| Pruritus |
2.3% |
| Rheumatoid Arthritis |
2.2% |
| Arthralgia |
2.1% |
| Pneumonia |
2.1% |
| Chronic Hepatitis C |
2.0% |
|
| Stomatitis |
15.7% |
| Vomiting |
12.2% |
| White Blood Cell Count Decreased |
7.8% |
| Abnormal Behaviour |
7.0% |
| Hepatic Function Abnormal |
7.0% |
| Rash |
5.2% |
| Hypoglycaemia |
4.3% |
| Liver Disorder |
4.3% |
| Renal Disorder |
4.3% |
| Asthma |
3.5% |
| Erythema Multiforme |
3.5% |
| Vein Discolouration |
3.5% |
| Viral Infection |
3.5% |
| Anaphylactic Shock |
2.6% |
| Atrial Fibrillation |
2.6% |
| Cerebral Infarction |
2.6% |
| Fracture |
2.6% |
| Hallucination, Auditory |
2.6% |
| Idiopathic Thrombocytopenic Purpura |
2.6% |
| Malaise |
2.6% |
|
